Tazofelone (Synonyms: LY 213829) |
Catalog No.GC64025 |
La tazofélone (LY 213829) est un inhibiteur de la cyclooxygénase-II (COX-II). La transformation de la tazofélone en métabolites sulfoxyde et quinol est principalement médiée par le CYP3A. Tazofelone peut être utilisé pour la recherche de maladies inflammatoires de l'intestin.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 107902-67-0
Sample solution is provided at 25 µL, 10mM.
Tazofelone (LY 213829) is a cyclooxygenase-II (COX-II) inhibitor. Tazofelone transform into sulfoxide and quinol metabolites is primarily mediated by CYP3A. Tazofelone can be used for the research of inflammatory bowel disease[1][2].
[1]. Leopold Franz Goetze,et al. Cox- ii inhibitors for improving reproductive success in a female animal. Patent: WO2007129169 A2.
[2]. Surapaneni SS, et al. In vitro biotransformation and identification of human cytochrome P450 isozyme-dependent metabolism of tazofelone. Drug Metab Dispos. 1997 Dec;25(12):1383-8.
Average Rating: 5
(Based on Reviews and 11 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *